Skip to main content
OpenTrials

Clinical trial condition

Plaque Psoriasis

Explore clinical trials studying Plaque Psoriasis. Study availability and eligibility vary by location and protocol.

298 public trials 24 recruiting studies
Refine in advanced search Browse all conditions

Plaque Psoriasis trial results

Completed

An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

NCT02326298

Conditions
Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Ps0005 504 San Diego, California, United States
  • Ps0005 502 West Des Moines, Iowa, United States
  • Ps0005 500 Baton Rouge, Louisiana, United States
  • Ps0005 506 Boston, Massachusetts, United States
View all 30 locations
View Trial Details
Completed

A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic Treatment

NCT02634801

Conditions
Plaque Psoriasis
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Augsburg, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Berlin, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bochum, Germany
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bonn, Germany
View all 21 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)

NCT02326272

Conditions
Plaque Psoriasis, Psoriasis, Skin Diseases, +2 more
Locations
  • Ps0002 203 Phoenix, Arizona, United States
  • Ps0002 214 Bakersfield, California, United States
  • Ps0002 212 Santa Monica, California, United States
  • Ps0002 204 Ormond Beach, Florida, United States
View all 23 locations
View Trial Details
Completed

Evaluation of Ixekizumab Using Auto-Injector or Prefilled Syringe in Participants With Moderate to Severe Plaque Psoriasis

NCT01777191

Conditions
Plaque Psoriasis
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Anaheim, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Bakersfield, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Santa Monica, California, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Miami, Florida, United States
View all 25 locations
View Trial Details
Completed

A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.

NCT02752776

Conditions
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque Psoriasis, +6 more
Locations
  • Novartis Investigative Site Geel, BEL, Belgium
  • Novartis Investigative Site Bruges, Belgium
  • Novartis Investigative Site Ghent, Belgium
  • Novartis Investigative Site Seraing, Belgium
View all 215 locations
View Trial Details
Completed

Study of Secukinumab Compared to Ustekinumab in Subjects With Plaque Psoriasis

NCT02826603

Conditions
Plaque Psoriasis
Locations
  • Novartis Investigative Site Anniston, Alabama, United States
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Birmingham, Alabama, United States
  • Novartis Investigative Site Mobile, Alabama, United States
View all 154 locations
View Trial Details
Completed

Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)

NCT02134210

Conditions
Plaque Psoriasis
Locations
  • Arizona Research Center Phoenix, Arizona, United States
  • Radiant Research - Scottsdale Scottsdale, Arizona, United States
  • Anaheim Clinical Trials Anaheim, California, United States
  • Dream Team Clinical Research Anaheim, California, United States
View all 100 locations
View Trial Details
Completed

A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.

NCT02486302

Conditions
Ankylosis, Arthritis, Arthritis, Psoriatic, +20 more
Locations
  • Rheumatologisches MVZ Dresden GmbH im Gesundheitszentrum Dresden - Klotzsche (GZDK) Dresden, Saxony, Germany
  • private practise Hemmerich Aachen, Germany
  • private practise Kurthen Aachen, Germany
  • Gesundheits- und Pflegezentrum Alsfeld gGmbH Alsfeld, Germany
View all 180 locations
View Trial Details

Related conditions